Rheumatology Network's Top 5: June 18, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 18, 2021.
Q&A: Guselkumab in Active Psoriatic Arthritis
In patients with psoriatic arthritis (PsA), guselkumab (Tremfya, Janssen Immunology) treatment reduced serum protein levels of acute phase and T-helper cell 17 (Th17) effector cytokines, achieving comparable levels to those in healthy controls.
Click on the image to view the story.
CreakyJoints Espanol
In today's episode, we sat down with Daniel Hernandez, MD, and Shilpa Venkatachalam, PhD, MPH, of CreakyJoints, to highlight health disparities in marginalized communities and introduce their exciting new venture, CreakyJoints Espanol.
Click on the image to view the story.
Jeffrey Stark, MD: New Sub-Category for Non-Radiographical Axial Spondyloarthritis
Jeffrey Stark, MD, discusses the statement UCB issued endorsing the creation of a new sub-category (M.45A) for non-radiographical axial spondyloarthritis (nr-axSpA).
Click on the image to view the story.
Alexis Ogdie, MD: Importance of Patient Experience in Psoriatic Arthritis Treatment
In partnership with CreakyJoints, Alexis Ogdie, MD discusses her study, “Real-World Patient Experience and Treatment Preferences in Patients With Psoriatic Arthritis,” which was recently presented at the EULAR 2021 Virtual Congress.
Click on the image to view the story.
Mehret Birru Talabi, MD, PhD: Medication Decision-Making During Pregnancy and Lactation Among Women With Inflammatory Arthritis
Rheumatology Network sat down with Mehret Birru Talabi, MD, PhD, to discuss the recent study published in ACR Open Rheumatology entitled, “Tough choices: Exploring medication decision-making during pregnancy and lactation among women with inflammatory arthritis."
Click on the image to view the story.
